University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Employees: -

Market Cap: -

Website

Clinical Trials

Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy

Phase 1

Completed

Conditions: Duchenne Muscular Dystrophy
Muscular Dystrophies
Limb-Girdle Muscular Dystrophy
Becker Muscular Dystrophy

Interventions: Other: Retrograde high pressure transvenous perfusion with normal saline

First Posted Date: 2009-04-02

Last Posted Date: 2015-03-09

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 16

Registration Number: NCT00873782

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Treatment De-Intensification and Residual HIV-1 in Youth

Completed

Conditions: HIV Infections
HIV-1

Interventions: Other: Blood draw

First Posted Date: 2009-03-24

Last Posted Date: 2017-02-28

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 34

Registration Number: NCT00867854

Locations: 🇺🇸
University of California at San Francisco, San Francisco, California, United States
🇺🇸
Children's National Medical Center, Washington, District of Columbia, United States
🇺🇸
Howard University - IMPAACT Site, Washington, District of Columbia, United States

and more 14 locations

Pilot Study for VeinoPlus to Improve Symptoms of Postthrombotic Syndrome (PTS)

Not Applicable

Completed

Conditions: Deep Vein Thrombosis
Post Thrombotic Syndrome
Venous Stasis Syndrome
Venous Insufficiency
Postphlebitic Syndrome

Interventions: Device: VeinOPlus

First Posted Date: 2009-03-09

Last Posted Date: 2017-11-29

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 12

Registration Number: NCT00858130

Locations: 🇺🇸
University of North Carolina at Chapel Hill; University of North Carolina Hospitals, Chapel Hill, North Carolina, United States

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

Phase 4

Terminated

Conditions: HIV Infections
Acute HIV Infection

Interventions: Drug: Darunavir
Drug: Ritonavir
Drug: Etravirine

First Posted Date: 2009-03-04

Last Posted Date: 2017-10-17

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 15

Registration Number: NCT00855413

Locations: 🇺🇸
The University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States
🇺🇸
Duke University, Durham, North Carolina, United States

Hemostatic Textile to Control Bleeding at Donor Graft Sites

Completed

Conditions: Wounds

Interventions: Device: Stasilon

First Posted Date: 2009-03-04

Last Posted Date: 2017-12-12

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 20

Registration Number: NCT00855569

Locations: 🇺🇸
North Carolina Jaycee Burn Center, Chapel Hill, North Carolina, United States

Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue

Phase 1

Completed

Conditions: HIV Infections
HIV/AIDS

Interventions: Drug: darunavir
Drug: Ritonavir
Drug: Etravirine

First Posted Date: 2009-03-04

Last Posted Date: 2011-05-13

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 13

Registration Number: NCT00855088

Locations: 🇺🇸
UNC Hospitals CTRC, Chapel Hill, North Carolina, United States

A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension

Phase 2

Withdrawn

Conditions: Pulmonary Hypertension
Sickle Cell Disease

Interventions: Other: RBC transfusion

First Posted Date: 2009-02-25

Last Posted Date: 2013-07-29

Lead Sponsor: University of North Carolina, Chapel Hill

Registration Number: NCT00850369

ID and Testing Via Friendship Networks

Completed

Conditions: Asymptomatic HIV
HIV Infections

Interventions: Other: Index Recruiter
Other: Friendship Network Member

First Posted Date: 2009-02-11

Last Posted Date: 2017-02-28

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 535

Registration Number: NCT00841360

Locations: 🇺🇸
University of Miami School of Medicine, Miami, Florida, United States
🇺🇸
Stroger Hospital of Cook County, Chicago, Illinois, United States
🇺🇸
Montefiore Medical Center, Bronx, New York, United States

Bronchoscopy Assisted Sampling of Cells and Fluid From the Lower Respiratory Tract of Human Subjects

Completed

Conditions: Respiratory Diseases

First Posted Date: 2009-02-10

Last Posted Date: 2013-09-05

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 30

Registration Number: NCT00840723

Locations: 🇺🇸
UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Effect Of Obesity On Ozone-Induced Airway Inflammation

Not Applicable

Completed

Conditions: Obesity

Interventions: Other: ozone, 0.4 ppm

First Posted Date: 2009-02-10

Last Posted Date: 2012-08-27

Lead Sponsor: University of North Carolina, Chapel Hill

Target Recruit Count: 40

Registration Number: NCT00839943

Locations: 🇺🇸
US EPA Human Studies Facility-UNC -CH campus, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy